Company Overview of Inviragen, Inc.
As of May 31, 2013, Inviragen, Inc. was acquired by Takeda America Holdings, Inc. Inviragen, Inc. develops life-saving vaccines to protect against various infectious diseases. It offers its products to protect against dengue viruses, as well as West Nile, swine-origin, chikungunya, plague/smallpox, and avian influenza diseases. The company's products also include INV21, a purified virus particle vaccine against hand, foot, and mouth disease. Inviragen, Inc. was founded in 2003 and is based in Fort Collins, Colorado. It has an additional office in Madison, Wisconsin.
2619 Midpoint Drive
Fort Collins, CO 80525
Founded in 2003
Key Executives for Inviragen, Inc.
Inviragen, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Inviragen, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.